Skip to content


Cytarabine, Depocyt, Vyxeos (cytarabine) is a small molecule pharmaceutical. Cytarabine was first approved as Cytarabine on 1982-01-01. It is used to treat leukemia, lymphoma, and meningeal neoplasms in the USA. It has been approved in Europe to treat myeloid leukemia acute.
Trade Name Vyxeos liposomal, known as Vyxeos
Common Name Cytarabine
Indication leukemia, lymphoma, meningeal neoplasms, myeloid leukemia acute
Drug Class Antineoplastics (arabinofuranosyl derivatives)
Get full access now